GlassScriptPhysician profile
Brandon Roane
NPI 1205256047
$4,191.57
in general payments reported to CMS, 2019-2025
16 companies · $539 in 2025
The $539 reported for 2025 was more than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.43 · 2021: $12.78 · 2022: $483 · 2023: $356 · 2024: $2,778 · 2025: $539.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,537 · Travel and Lodging: $1,121 · Gift: $14.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,537.01 |
| Travel and Lodging | $1,121.07 |
| Gift | $14.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,323.71 | 2022-2024 | |
| Medical Device Business Services, INC. | $736.43 | 2024 | Harmonic |
| Myriad Genetic Laboratories, INC. | $587.58 | 2022-2025 | Precisetumor, Myrisk |
| Glaxosmithkline, LLC. | $391.72 | 2022-2024 | Jemperli, Zejula |
| Medtronic, INC. | $251.46 | 2025 | Ligasure |
| Ethicon US, LLC | $239.94 | 2023-2024 | Enseal X1, Vistaseal, Enseal |
| Meditrina | $155.27 | 2023-2024 | |
| Dilon Technologies, INC. | $149.68 | 2024 | Hemoblast Bellows |
| Genmab U.S., INC. | $108.72 | 2022 | |
| Merck Sharp & Dohme LLC | $89.59 | 2022-2025 | Keytruda, Lynparza |
| Axogen | $61.67 | 2025 | |
| Clovis Oncology, INC. | $22.43 | 2019 | |
| Eisai INC. | $22.33 | 2024 | |
| Smith+Nephew, INC. | $21.00 | 2023 | Pico |
| Abbvie INC. | $17.26 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $12.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Roane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.